Doptelet
My Prescription
Payment
Select pharmacy
$13,442.18
Print or send this coupon to your phone
WalmartPowered byAbout Doptelet
Drug Details
Avatrombopag, marketed as Doptelet, is a medication designed to increase platelet levels in adults. It is primarily used for individuals with chronic liver disease (CLD) who have low platelet counts before undergoing medical or dental procedures. This is crucial as low platelet levels can significantly heighten the risk of excessive bleeding during such procedures. Avatrombopag is also beneficial for adults with chronic immune thrombocytopenia (ITP), a condition characterized by persistently low platelet counts that can lead to serious bleeding issues, especially when other treatments have not been effective. This medication functions as a thrombopoietin (TPO) receptor agonist. TPO is a natural hormone that prompts the body to produce more platelets, which are essential blood cells that aid in clotting to prevent bleeding. By mimicking TPO, avatrombopag helps to elevate platelet levels, thereby minimizing the risk of severe bleeding. Doptelet is conveniently administered orally once daily. However, it is important to note that it may be costly, as there is no generic version available. Always consult healthcare professionals, such as doctors, nurses, or pharmacists, for personalized medical advice before starting any new medication.
Price history for Doptelet
30 Tablets, 20MG
Average retail price for Doptelet
Average SaveHealth price for Doptelet
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Doptelet dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20MG | 30 Tablets | $13,442.18 | $448.07 |
| 20MG | 10 Tablets | $4,484.06 | $448.41 |
| 20MG | 15 Tablets | $6,723.59 | $448.24 |
Doptelet FAQs
Doptelet is used to treat thrombocytopenia, which is a condition characterized by a low platelet count. It is specifically indicated for adults with chronic liver disease who are scheduled to undergo a medical or dental procedure, as well as for adults with chronic immune thrombocytopenia who have had an insufficient response to previous treatment.
Promacta (eltrombopag) and Doptelet (avatrombopag) are both medications used to treat thrombocytopenia, a condition characterized by low platelet counts. They are thrombopoietin receptor agonists, which means they work by stimulating the production of platelets in the bone marrow.The primary differences between the two include:1. **Indications**: While both are used to treat thrombocytopenia, they may be approved for different specific conditions or patient populations. For example, Promacta is used for chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia. Doptelet is used for chronic liver disease-associated thrombocytopenia and chronic ITP.2. **Administration**: Promacta is available in tablet form and as an oral suspension, while Doptelet is available in tablet form only.3. **Dosing and Administration**: The dosing regimen and specific administration instructions may vary between the two medications, depending on the condition being treated and the patient's response.4. **Side Effects and Interactions**: While both medications have similar side effects, the specific profile and potential drug interactions may differ slightly.It is important for patients to consult with their healthcare provider to determine which medication is most appropriate for their specific condition and needs.
The cost of Doptelet can vary depending on factors such as the pharmacy, location, insurance coverage, and dosage prescribed. It is recommended to check with local pharmacies or consult with a healthcare provider or insurance company for the most accurate and up-to-date pricing information.
Doptelet (avatrombopag) is not commonly associated with causing blood clots. However, as it is used to increase platelet counts, there is a potential risk for thrombotic events, especially in patients with chronic liver disease or other risk factors for thrombosis. It is important for patients to discuss their individual risk factors with their healthcare provider.
Doptelet may be covered by Medicare, but coverage can vary depending on the specific Medicare plan. It is typically covered under Medicare Part D, which is the prescription drug plan. Patients should check with their specific Medicare plan provider to confirm coverage details, including any potential out-of-pocket costs or prior authorization requirements.